- Raised $6M funding round, Dec 2017
- Raised $250k grant, Jun 2019
- Raised $1M funding round, Jan 2016
About
StemRad provides personal radiation-protection solutions. Its technology offers lifesaving protection from penetrating ionizing radiation, making the lives of first responders, military personnel, utility personnel, medical teams, and astronauts safer without compromising mission objectives. The company has developed the 360 Gamma, a wearable shield that provides lifesaving protection from gamma radiation. StemRads 360 Gamma lowers radiation exposure to the most critical radiosensitive organs, including the colon, stomach, and ovaries, significantly reducing the associated risks in accordance with the ALARA safety principle. The StemRad 360 Gamma is worn around the pelvic area, which contains the bodys largest concentration of bone marrow. StemRad is also the developer of AstroRad, personal protective equipment designed to be worn by astronauts beyond low Earth orbit. Co-developed by StemRad and Lockheed Martin, AstroRad protects bone marrow to prevent acute radiation sickness, but is further expanded to also protect the lungs, stomach, colon, breasts, and ovaries organs that are particularly vulnerable to the development of cancer due to chronic exposure to radiation.
Funding history · 4 rounds · $7.8M total
Q&A
- What is StemRad's primary focus?
- StemRad specializes in providing personal radiation-protection solutions, offering lifesaving protection from penetrating ionizing radiation for various personnel including first responders, military, utility, medical teams, and astronauts.
- What is the 360 Gamma product?
- The 360 Gamma is a wearable shield developed by StemRad that provides lifesaving protection from gamma radiation. It is worn around the pelvic area to lower radiation exposure to critical radiosensitive organs.
- What is AstroRad and who co-developed it?
- AstroRad is personal protective equipment designed by StemRad to be worn by astronauts beyond low Earth orbit. It was co-developed by StemRad and Lockheed Martin.
- When was StemRad founded?
- StemRad was founded in October 2011.
- What is StemRad's total funding to date?
- StemRad has raised a total of $7,809,000 in funding.
- Which investor participated in StemRad's $6,000,000 funding round in December 2017?
- Jeff Vinik participated in StemRad's $6,000,000 funding round in December 2017.
- What was StemRad's most recent funding round?
- StemRad received a Grant of $250,000 in June 2019 from Space Florida.
- Where is StemRad's headquarters located?
- StemRad's headquarters is located in Tel Aviv-Yafo, Israel.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | stemrad.com |
|---|---|
| linkedin.com/company/3505511 | |
| facebook.com/stemrad | |
| YouTube | youtube.com/channel/UCgMpo6Ecfw6d4gMmXoITXgw |
| Wikipedia | en.wikipedia.org/wiki/StemRad |
| Wikidata | wikidata.org/wiki/Q18385371 |
Identifiers & details
| Founded | 2011-10 |
|---|---|
| Employees (exact) | 18 |
| Offices | Tampa |
| Wikidata QID | Q18385371 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | stemrad.com |
|---|
Wikidata
| QID | Q18385371 |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|